KalVista Pharmaceuticals (KALV) Earnings
|
Expand Research on KALV
| Next EPS Date | 9/3/26 | EPS Growth Rate | +58.7% |
|---|---|---|---|
| Average EPS % Beat Rate | -4.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
9/3/26  |
Q326 | N/A | -$0.38 | N/A | N/A | $38.34M | N/A | N/A | N/A | ||
| 12/4/25 |
Q226 | -$0.92 | -$0.96 | +$0.04 | $13.69M | $7.17M | N/A |  | | Details | |
| 11/11/25 |
Q226 | N/A | -$0.96 | N/A | N/A | $7.17M | N/A | N/A | N/A | ||
| 9/11/25 | Q126 | -$1.12 | -$0.96 | -$0.16 | $1.43M | $951.67K | N/A | | | Details | |
| 7/8/25 |
Q425 | N/A | -$0.85 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 7/7/25 |
Q425 | N/A | -$0.85 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 7/3/25 |
Q425 | N/A | -$0.85 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/12/25 | Q325 | -$0.92 | -$0.87 | -$0.05 | N/A | N/A | N/A | | | Details |
